In this study, we are interested in the global benefit of the tested product as complementary care to a topical medical treatment during a 3 month-associated treatment phase followed by a 3 month-maintenance phase, compared to a light moisturizing cream, in teenagers and adults with acne. We also want to evaluate the tolerance of the tested product in association and in maintenance of the topical medical treatment.
Male or Female aged between 14 and 24 years (included)
Subject with facial acne with score index severity IGA = 2 or 3, assessed on a scale ranged from 0 to 4.
Subject for whom a prescription of 12 weeks of a reference topical medical treatment is required from the day of the inclusion visit, for mild to moderate face acne
Facial skin disease other than acne, skin abnormalities, or dermatological condition on the face liable to interfere with the study assessments
Acne conglobata, Acne fulminans, nodulocystic acne or acneiform eruptions, according to investigator's assessment
Other type of pigmentation disorder than acne-related PIH liable to interfere with the study assessments according to the investigator